News
Titan Biotech consolidated net profit rises 61.73% in the September 2026 quarter
05-Nov-2026 | 16:22
Sales rise 40.68% to Rs 76.46 crore
Net profit of Titan Biotech rose 61.73% to Rs 12.55 crore in the quarter ended September 2026 as against Rs 7.76 crore during the previous quarter ended September 2025. Sales rose 40.68% to Rs 76.46 crore in the quarter ended September 2026 as against Rs 54.35 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 76.46 | 54.35 | 41 |
| OPM % | 19.63 | 17.17 | - |
| PBDT | 16.45 | 10.43 | 58 |
| PBT | 15.13 | 9.22 | 64 |
| NP | 12.55 | 7.76 | 62 |
Powered by Capital Market - Live News